Cointime

SolveBio

company

About

SolveBio deploys technology and on-demand expertise to drive precision medicine. We monitor, gather, and secure Genomic Intelligence.

  • 11 - 50

Highlights

Total Funding Amount
$1.49M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.49M
Industries
Biotechnology,Genetics,Health Diagnostics
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

SolveBio, founded in 2013, is a contextual knowledge hub focused on enabling pharma, biotech, and diagnostic organizations to effectively connect and use external and internal genomic information. SolveBio extracts, evaluates, and unifies complex, disparate biomedical data for life science enterprises. SolveBio is based in New York and is backed by Andreessen Horowitz, Max Levchin, Nat Turner, Elad Gil, SV Angel, Faridan Capital and other leading life sciences and technology investors. For more information, visit www.solvebio.com

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.49M
SolveBio has raised a total of $1.49M in funding over 2 rounds. Their latest funding was raised on Jan 8, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 8, 2018 Grant $1.49M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
SolveBio is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
Содержание
компания